🇺🇸 FDA
Patent

US 10765694

Compositions and methods for delivering inhibitory oligonucleotides

granted A61KA61K31/713A61K47/642

Quick answer

US patent 10765694 (Compositions and methods for delivering inhibitory oligonucleotides) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Sep 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Sep 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/713, A61K47/642, A61K47/6455, A61P